Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01340066 · ClinicalTrials.gov registry record · Phase 1
Safety and Efficacy Study of a New Treatment for Symptoms of Urinary Incontinence
A Phase 1 study, sponsored by Beech Tree Labs.
- Completed
- Registry status
- Phase 1
- Development phase
- 94
- Enrollment target
NCT01340066 is a Phase 1 study that has completed, run by Beech Tree Labs. The registered enrollment target is 94 participants.
The verdict
NCT01340066, a Phase 1 study, has completed, sponsored by Beech Tree Labs.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 94 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a new drug treatment is effective for the treatment of symptoms of urinary incontinence.
Interventions
- DRUG matching placebo
- DRUG UISH001
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2011-04 |
| Est. Completion | 2012-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01340066
The ClinicalTrials.gov registry entry for NCT01340066 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beech Tree Labs, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which matching placebo is the first listed.
NCT01340066 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01340066 about?
NCT01340066 is a clinical study titled "Safety and Efficacy Study of a New Treatment for Symptoms of Urinary Incontinence". The purpose of this study is to determine if a new drug treatment is effective for the treatment of symptoms of urinary incontinence.
What is the current status of trial NCT01340066?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 94 participants. The study started on 2011-04. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01340066?
The interventions under investigation include: matching placebo (DRUG), UISH001 (DRUG).
Who is sponsoring clinical trial NCT01340066?
This trial is sponsored by Beech Tree Labs, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.